Lars Erik Bryld

Lars Erik Bryld

Clinical Associate Professor

Member of:

  • Dermatovenerology


Publication year:
All
1 - 3 out of 3Page size: 10
  1. 2021
  2. Published

    Outcomes following a Mandatory Nonmedical Switch from Adalimumab Originator to Adalimumab Biosimilars in Patients with Psoriasis

    Loft, N., Egeberg, Alexander, Rasmussen, M. K., Bryld, Lars Erik, Nissen, Christoffer Valdemar S, Dam, T. N., Ajgeiy, K. K., Iversen, L. & Skov, Lone, 2021, In: JAMA Dermatology. 157, 6, p. 676-683

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Reply to: “Comment on ‘Drug survival of secukinumab and ixekizumab for moderate-to-severe plaque psoriasis'”

    Egeberg, Alexander, Bryld, Lars Erik & Skov, Lone, 2021, In: Journal of the American Academy of Dermatology. 85, 6, p. e379

    Research output: Contribution to journal › Letter › Research › peer-review

  4. Published

    Response to biologics during the first six months of therapy in biologic-naïve patients with psoriasis predicts risk of disease flares: A danish nationwide study

    Loft, N., Egeberg, A., Rasmussen, M. K., Bryld, Lars Erik, Nissen, C. V., Dam, T. N., Ajgeiy, K. K., Iversen, L. & Skov, Lone, 2021, In: Acta Dermato-Venereologica. 101, 1, p. 1-7 7 p., adv00357.

    Research output: Contribution to journal › Journal article › Research › peer-review

ID: 32369880